ensereptide-arkiv - BioStock

Patent och studie i fokus för Promore Pharma

Patents and study in focus for Promore Pharma

22 March, 2023

Promore Pharma

Promore Pharma’s CEO on hopes for 2023

10 January, 2023

Promore Pharmas kvartalsrapport Q2

Promore Pharma advancing according to plan

5 September, 2022

Patent Promore Pharma

Promore Pharma strengthens IP-protection

15 August, 2022

Promore Pharma fas II-studie

Last clinic visit completed in Promore Pharma’s ensereptide study

17 June, 2022

Promore Pharmas Q1 studieavancemang

Promore Pharma’s Q1 characterised by study progress

25 May, 2022

Promore Pharma leg wounds

Promore Pharma aims to accelerate healing of venous leg ulcers

16 May, 2022

Labtalk

Promore Pharma’s phase II study running according to plan

7 April, 2022

Promore Pharma

Promore Pharma initiates patient recruitment

21 February, 2022

Promore Pharma

Promore Pharma prepares phase II study

20 January, 2022